Evidence map›Paper›PMID 42905261›Full record

ArticleVirchows Archiv : an international journal of pathology2026

Primary and secondary vasculitis of the lung - critical evaluation of the update classification.

Helmut Popper

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Helmut PopperD&R Institute of Pathology, Medical University Graz, Neue Stiftingtalstrasse 6, Graz, 8036, Austria. helmut.popper@medunigraz.at.ORCID http://orcid.org/0000-0003-4970-1265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vasculitis in the lung can be separated into infectious and non-infectious, and in systemic and localized ones. Three major categories in the lung are known, previously named Wegener's granulomatosis, Churg-Strauss syndrome, and microscopic polyangiitis. The classification of vasculitis was proposed in 1994, including a size distribution for each type, an antinuclear and anticytoplasmic antibody profile (ANCA), and an organ location. In an updated classification (2011) the names for two of the most common primary vasculitis were replaced: Wegener`s granulomatosis by Granulomatosis with polyangiitis (GPA) and Churg-Strauss syndrome by Eosinophilic granulomatosis with polyangiitis (EGPA). This proposal has been critically discussed in meetings of the pulmonary working group of ESP (2025) and the Pulmonary Pathology Society Meeting (Quebec, 2026). There were doubts about the usefulness of the when applied in pulmonary pathology. A new proposal is presented here. This classification is based on pattern recognition, such as neutrophilic, eosinophilic, and other forms of vasculitis. As many other types of pulmonary vasculitis were not covered in the old nor in the new proposal, several variants are added. This applies for example to vasculitis seen in autoimmune diseases. There is no doubt, that a classification of vasculitis is important, to sort the type of vasculitis. If possible, such a classification should be useful not only in lung pathology but more general in any other organ system. However, in several organ systems the clinical picture and the laboratory test allow a diagnosis, which is not the case in lung. On CT scan most types of pulmonary vasculitis present with ground glass opacitis with/without nodules. Often biopsies are labelled as interstitial lung disease.

Indexed as

ClassificationInfectiousNon-infectious vasculitisPulmonarySystemic vasculitisVasculitis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.